Company news
Nemaura Medical, Inc. (OTC:NMRD) news
Nemaura Medical, Inc. news releases on 6ix. Latest, Jan 23, 2018: Nemaura Medical Inc. Announces Uplisting to NASDAQ Capital Market on January 25, 2018
Press releases & updates
Nemaura Medical Inc. Announces Uplisting to NASDAQ Capital Market on January 25, 2018
January 23, 2018
Nemaura Announces Completion of SugarBEAT® European Clinical Trial Programme and Positive Interim Results
December 21, 2017
Nemaura Announces Successful SugarBEAT® Interim Precision Study Results
December 6, 2017
Nemaura Medical Inc. Reports Second Quarter 2017 Financial Results
November 2, 2017
WallStreet Research™ Announces Availability of Corporate Profile Coverage on Nemaura Medical, Inc.
September 26, 2017
Nemaura Announces Successful Interim Results for SugarBEAT® European Clinical Trials
September 21, 2017
Nemaura Develops Medical Grade SugarBEAT® Android App for Diabetes Management
August 29, 2017
Nemaura Signs Heads of Terms for sugarBEAT® with Device Technologies for Australia and New Zealand
August 15, 2017
Nemaura Medical Inc. Reports First Quarter 2017 Financial Results
August 9, 2017
Nemaura Appoints Thomas Moore to Board of Directors as Independent Director
August 3, 2017
Nemaura Develops Rechargeable Transmitter for sugarBEAT®
August 1, 2017
Nemaura Appoints Dr. Salim Natha to Board of Directors as Independent Director, Chair of Compensation Committee
July 26, 2017
Nemaura Signs Letter of Intent for Licensing Agreement with TPM for GCC Region
July 20, 2017
Nemaura Appoints Timothy Johnson to Board of Directors as Independent Director, Chairman of Audit and Corporate Governance Committees
July 17, 2017
Nemaura Medical Inc. Announces Uplist to OTCQB
July 10, 2017
OTC Markets Group Welcomes New OTCQB Companies – June 30
June 30, 2017
Nemaura Medical Inc. Reports Full Year Financial Results
June 28, 2017